Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors.
Alexandra M GaynorAnam AhsanDuane JungElizabeth SchofieldYuelin LiElizabeth RyanTim A AhlesJames C RootPublished in: Journal of cancer survivorship : research and practice (2022)
The sensitivity of these tasks to subtle cognitive deficits has advantages for initial diagnosis of cancer-related cognitive dysfunction, as well as detecting changes in survivors' cognitive function over time. The remote delivery of the battery may help overcome barriers associated with in-office administration and increase access to neurocognitive evaluation.